Celltrion’s biosimilar Remicade gets EU green light
LONDON (Reuters) – European regulators have recommended approval of a copycat version of the blockbuster rheumatoid arthritis drug Remicade, the … Continue reading → The post Celltrion’s biosimilar...
View ArticleEurope approves first biosimilar antibody drug
LONDON (Reuters) – The European Commission has approved the first copycat version of an antibody-based drug, clearing the way for … Continue reading → The post Europe approves first biosimilar antibody...
View ArticleCORRECTED-New factory puts Iceland in biosimilar drugs race
Iceland is joining the race to make copycat versions of complex biotech drugs with an investment of $ 250 million … Continue reading → The post CORRECTED-New factory puts Iceland in biosimilar drugs...
View ArticleNovartis wins approval for first US biosimilar drug
U.S. regulators on Friday gave a green light to sales of the country’s first copied version of a biotechnology drug, … Continue reading → The post Novartis wins approval for first US biosimilar drug...
View Article
